MoonLake Immunotherapeutics - Class A Ordinary Shares (MLTX)
NASDAQ · Healthcare
$19.05-3.20%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $1.68B
- P/E ratio
- —
- EPS
- —
- Volume
- 615,386
- 52-week high
- —
- 52-week low
- —
- Open
- $19.95
- Day high
- $20.29
- Day low
- $19.02
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$227.32M | -$3.53 |
| 2024 | — | -$118.94M | -$1.89 |
| 2023 | — | -$36.01M | -$0.73 |
| 2022 | — | -$49.97M | -$1.70 |
| 2021 | — | -$53.64M | -$6.84 |
About MoonLake Immunotherapeutics - Class A Ordinary Shares
MoonLake Immunotherapeutics operates as a clinical-stage biopharmaceutical company, concentrating its efforts on discovering and developing novel therapies. The company's primary focus is the advancement of Sonelokimab, an innovative, investigational Nanobody-based treatment engineered to target inflammatory conditions. Currently, Sonelokimab is undergoing mid-stage (Phase II) clinical trials for a range of inflammatory diseases, including hidradenitis suppurativa, psoriatic arthritis, and both ankylosing spondylitis and radiographic axial spondyloarthritis. Established in 2021, MoonLake Immunotherapeutics is based in Zug, Switzerland.
- CEO
- Jorge Santos da Silva
- Employees
- 130
- Country
- CH
- IPO date
- Oct 20, 2020
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is MoonLake Immunotherapeutics - Class A Ordinary Shares's stock price today?
- MLTX is trading at $19.05 as of Jul 20, 2026.
- What is MoonLake Immunotherapeutics - Class A Ordinary Shares's market cap?
- MoonLake Immunotherapeutics - Class A Ordinary Shares (MLTX) has a market capitalization of $1.68B.
- Does MoonLake Immunotherapeutics - Class A Ordinary Shares pay a dividend?
- MoonLake Immunotherapeutics - Class A Ordinary Shares did not pay a dividend in its most recent reported fiscal year.
- What sector is MoonLake Immunotherapeutics - Class A Ordinary Shares in?
- MoonLake Immunotherapeutics - Class A Ordinary Shares operates in the Healthcare sector.